Sophie Paczesny Pediatric Blood and Marrow Transplant Program University of Michigan Biography Publications Institution JoVE Articles Sophie Paczesny has not added a biography. If you are Sophie Paczesny and would like to personalize this page please email our Author Liaison for assistance. Publications TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Oct, 2012 | Pubmed ID: 22469883 Acute Graft-versus-host Disease Biomarkers Measured During Therapy Can Predict Treatment Outcomes: a Blood and Marrow Transplant Clinical Trials Network Study Blood. Apr, 2012 | Pubmed ID: 22383800 Plasma Biomarkers of Lower Gastrointestinal and Liver Acute GVHD Blood. Mar, 2012 | Pubmed ID: 22286196 Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-host Disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2012 | Pubmed ID: 22226094 Role of Cytokines in the Pathophysiology of Acute Graft-versus-host Disease (GVHD): Are Serum/plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)? Current Stem Cell Research & Therapy. May, 2012 | Pubmed ID: 22023620 Regenerating Islet-derived 3-alpha is a Biomarker of Gastrointestinal Graft-versus-host Disease Blood. Dec, 2011 | Pubmed ID: 21979939 Clofarabine and Busulfan Conditioning Facilitates Engraftment and Provides Significant Antitumor Activity in Nonremission Hematologic Malignancies Blood. Oct, 2011 | Pubmed ID: 21841163 Translational Research Efforts in Biomarkers and Biology of Early Transplant-related Complications Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2011 | Pubmed ID: 21195297 Immunotherapy Through T-cell Receptor Gene Transfer Induces Severe Graft-versus-host Disease Immunotherapy. Nov, 2010 | Pubmed ID: 21091111 Novel Proteins Associated with Risk for Coronary Heart Disease or Stroke Among Postmenopausal Women Identified by In-depth Plasma Proteome Profiling Genome Medicine. 2010 | Pubmed ID: 20667078 Elafin is a Biomarker of Graft-versus-host Disease of the Skin Science Translational Medicine. Jan, 2010 | Pubmed ID: 20371463 Frequency of CD4(+)CD25(hi)FOXP3(+) Regulatory T Cells Has Diagnostic and Prognostic Value As a Biomarker for Acute Graft-versus-host-disease Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2010 | Pubmed ID: 20302964 Postmenopausal Estrogen and Progestin Effects on the Serum Proteome Genome Medicine. 2009 | Pubmed ID: 20034393 Acute Graft-versus-host Disease: New Treatment Strategies Current Opinion in Hematology. Nov, 2009 | Pubmed ID: 19812490 Mesenchymal Stem Cells for Treatment and Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation Current Stem Cell Research & Therapy. Dec, 2009 | Pubmed ID: 19500066 Application of Serum Proteomics to the Women's Health Initiative Conjugated Equine Estrogens Trial Reveals a Multitude of Effects Relevant to Clinical Findings Genome Medicine. 2009 | Pubmed ID: 19402886 Plasma Biomarkers in Graft-versus-host Disease: a New Era? Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jan, 2009 | Pubmed ID: 19147075 A Biomarker Panel for Acute Graft-versus-host Disease Blood. Jan, 2009 | Pubmed ID: 18832652 Plasma Elevations of Tumor Necrosis Factor-receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-host Disease Severity and Overall Survival in Pediatric Patients Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Jul, 2008 | Pubmed ID: 18541194 Change in Plasma Tumor Necrosis Factor Receptor 1 Levels in the First Week After Myeloablative Allogeneic Transplantation Correlates with Severity and Incidence of GVHD and Survival Blood. Aug, 2008 | Pubmed ID: 18502834 Plasma Proteome Profiling of a Mouse Model of Breast Cancer Identifies a Set of Up-regulated Proteins in Common with Human Breast Cancer Cells Journal of Proteome Research. Apr, 2008 | Pubmed ID: 18311905 Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells Through Activation of the Notch Pathway Journal of Immunology (Baltimore, Md. : 1950). Feb, 2008 | Pubmed ID: 18209056 Etanercept Plus Methylprednisolone As Initial Therapy for Acute Graft-versus-host Disease Blood. Feb, 2008 | Pubmed ID: 18042798 Efficient Generation of CD34+ Progenitor-derived Dendritic Cells from G-CSF-mobilized Peripheral Mononuclear Cells Does Not Require Hematopoietic Stem Cell Enrichment Journal of Leukocyte Biology. Apr, 2007 | Pubmed ID: 17229904 Long-term Outcomes in Patients with Metastatic Melanoma Vaccinated with Melanoma Peptide-pulsed CD34(+) Progenitor-derived Dendritic Cells Cancer Immunology, Immunotherapy : CII. Oct, 2006 | Pubmed ID: 16331519 Spontaneous Proliferation and Type 2 Cytokine Secretion by CD4+T Cells in Patients with Metastatic Melanoma Vaccinated with Antigen-pulsed Dendritic Cells Journal of Clinical Immunology. May, 2005 | Pubmed ID: 15981095 Immunotherapy Via Dendritic Cells Advances in Experimental Medicine and Biology. 2005 | Pubmed ID: 15932026 Boosting Vaccinations with Peptide-pulsed CD34+ Progenitor-derived Dendritic Cells Can Expand Long-lived Melanoma Peptide-specific CD8+ T Cells in Patients with Metastatic Melanoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Mar-Apr, 2005 | Pubmed ID: 15725960 Measuring Melanoma-specific Cytotoxic T Lymphocytes Elicited by Dendritic Cell Vaccines with a Tumor Inhibition Assay in Vitro Journal of Immunotherapy (Hagerstown, Md. : 1997). Mar-Apr, 2005 | Pubmed ID: 15725959 Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells The Journal of Experimental Medicine. Jun, 2004 | Pubmed ID: 15173207 Dendritic Cells As Vectors for Immunotherapy of Cancer Seminars in Cancer Biology. Dec, 2003 | Pubmed ID: 15001163 Single Injection of CD34+ Progenitor-derived Dendritic Cell Vaccine Can Lead to Induction of T-cell Immunity in Patients with Stage IV Melanoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep-Oct, 2003 | Pubmed ID: 12973032 Dendritic Cells: Controllers of the Immune System and a New Promise for Immunotherapy Annals of the New York Academy of Sciences. Apr, 2003 | Pubmed ID: 12727638 Высокая пропускная способность последовательного ELISA для проверки биомаркеров острого трансплантат против хозяина Bryan Fiema*1, Andrew C. Harris*1, Aurelie Gomez1, Praechompoo Pongtornpipat1, Kelly Lamiman1, Mark T. Vander Lugt1, Sophie Paczesny1 1Pediatric Blood and Marrow Transplant Program, University of Michigan JoVE 4247 Medicine
Высокая пропускная способность последовательного ELISA для проверки биомаркеров острого трансплантат против хозяина Bryan Fiema*1, Andrew C. Harris*1, Aurelie Gomez1, Praechompoo Pongtornpipat1, Kelly Lamiman1, Mark T. Vander Lugt1, Sophie Paczesny1 1Pediatric Blood and Marrow Transplant Program, University of Michigan JoVE 4247 Medicine